an alternative form of the protein. J Biol Chem 276:39438-39447
30. Sabol SL, Brewer HB, Jr., Santamarina-Fojo S 2005 The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 46:2151-2167
31. Landrier JF, Grober J, Demydchuk J, Besnard P 2003 FXRE can function as an LXRE in the promoter of human ileal bile acid-binding protein (I-BABP) gene. FEBS Lett 553:299-303
32. Okuwaki M, Takada T, Iwayanagi Y, Koh S, Kariya Y, Fujii H, Suzuki H 2007 LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR. Pharm Res 24:390-398
33. Hu X, Li S, Wu J, Xia C, Lala DS 2003 Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol 17:1019-1026 34. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M,
Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG, Glass CK 2003 Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 23:5780-5789
35. Alland L, Muhle R, Hou H, Jr., Potes J, Chin L, Schreiber-Agus N, DePinho RA 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55
36. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD,
Rose DW, Glass CK, Rosenfeld MG 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
37. Huuskonen J, Fielding PE, Fielding CJ 2004 Role of p160 coactivator complex in the activation of liver X receptor. Arterioscler Thromb Vasc Biol 24:703-708
38. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959
39. Xu J, Li Q 2003 Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17:1681-1692
40. Abraham SE, Lobo S, Yaciuk P, Wang HG, Moran E 1993 p300, and p300-associated proteins, are components of TATA-binding protein (TBP)
complexes. Oncogene 8:1639-1647
41. Dallas PB, Yaciuk P, Moran E 1997 Characterization of monoclonal
antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J Virol 71:1726-1731
42. Felzien LK, Farrell S, Betts JC, Mosavin R, Nabel GJ 1999 Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator. Mol Cell Biol 19:4241-4246
43. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J 2003 A role for cofactor-cofactor and cofactor-cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. Embo J 22:2146-2155
44. Unno A, Takada I, Takezawa S, Oishi H, Baba A, Shimizu T, Tokita A, Yanagisawa J, Kato S 2005 TRRAP as a hepatic coactivator of LXR and FXR function. Biochem Biophys Res Commun 327:933-938
45. Oberkofler H, Schraml E, Krempler F, Patsch W 2003 Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha. Biochem J 371:89-96
46. Herzog B, Hallberg M, Seth A, Woods A, White R, Parker MG 2007 The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol 21:2687-2697
47. Gabbi C, Warner M, Gustafsson JA 2008 Liver X Receptor {beta}:
Emerging Roles in Physiology and Diseases. Mol Endocrinol
48. Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P 2003 Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 278:10443-10449
49. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P 2003 Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219
50. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, Miller AR, Dai J, Foxworthy P, Gao H, Ryan TP, Jiang XC, Burris TP, Eacho PI, Etgen GJ 2003
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 278:1131-1136
51. Wang Y, Rogers PM, Su C, Varga G, Stayrook KR, Burris TP 2008 Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J Biol Chem 283:26332-26339
52. Russell DW, Setchell KD 1992 Bile acid biosynthesis. Biochemistry 31:4737-4749
53. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ 1998 Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704 54. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M,
Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA 2001 Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565-573
55. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM 1997
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272:3137-3140
56. Chiang JY, Kimmel R, Stroup D 2001 Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262:257-265
57. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA 2003 Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 17:386-394
58. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA 2000 A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526
59. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ 2000 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515
60. Nitta M, Ku S, Brown C, Okamoto AY, Shan B 1999 CPF: an orphan nuclear receptor that regulates liver-specific expression of the human
cholesterol 7alpha-hydroxylase gene. Proc Natl Acad Sci U S A 96:6660-6665 61. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP,
Billheimer JT, Rothblat GH, Rader DJ 2006 Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113:90-97
62. Stulnig TM, Steffensen KR, Gao H, Reimers M, Dahlman-Wright K, Schuster GU, Gustafsson JA 2002 Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol 62:1299-1305
63. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH 2002 Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110:671-680
64. Remaley AT, Bark S, Walts AD, Freeman L, Shulenin S, Annilo T, Elgin E, Rhodes HE, Joyce C, Dean M, Santamarina-Fojo S, Brewer HB, Jr.
2002 Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem Biophys Res Commun 295:276-282 65. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B,
Heyman RA, Dietschy JM, Mangelsdorf DJ 2000 Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-1529
66. Costet P, Luo Y, Wang N, Tall AR 2000 Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275:28240-28245
67. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS 2005 Targeted inactivation of hepatic Abca1 causes profound
hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 115:1333-1342
68. Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR 2006 Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 116:1052-1062
69. Van Eck M, Singaraja RR, Ye D, Hildebrand RB, James ER, Hayden MR, Van Berkel TJ 2006 Macrophage ATP-binding cassette transporter A1
overexpression inhibits atherosclerotic lesion progression in low-density
lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 26:929-934 70. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC,
Frank J, Francone OL, Edwards PA 2005 ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.
Cell Metab 1:121-131
71. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, Cartland
synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26:534-540
72. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P 2002 Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 99:7604-7609
73. Levin N, Bischoff ED, Daige CL, Thomas D, Vu CT, Heyman RA, Tangirala RK, Schulman IG 2005 Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 25:135-142
74. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, Kuipers F 2002
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277:34182-34190
75. Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, Romijn JA, Groot PH, Reijngoud DJ, Kuipers F 2005 Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289:E829-838
76. Groot PH, Pearce NJ, Yates JW, Stocker C, Sauermelch C, Doe CP, Willette RN, Olzinski A, Peters T, d'Epagnier D, Morasco KO, Krawiec JA, Webb CL, Aravindhan K, Jucker B, Burgert M, Ma C, Marino JP, Collins JL, Macphee CH, Thompson SK, Jaye M 2005 Synthetic LXR agonists increase LDL in CETP species. J Lipid Res 46:2182-2191
77. Kim JB, Spotts GD, Halvorsen YD, Shih HM, Ellenberger T, Towle HC, Spiegelman BM 1995 Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain. Mol Cell Biol 15:2582-2588
78. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S,
Yamada N 1999 Sterol regulatory element-binding protein-1 as a key
transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274:35832-35839
79. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS 2002 Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277:9520-9528
80. Dentin R, Pegorier JP, Benhamed F, Foufelle F, Ferre P, Fauveau V, Magnuson MA, Girard J, Postic C 2004 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279:20314-20326
81. Uyeda K, Repa JJ 2006 Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4:107-110
82. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, Uyeda K 2001 A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98:9116-9121
83. Becard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferre P, Foufelle F 2001 Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50:2425-2430
84. Foretz M, Guichard C, Ferre P, Foufelle F 1999 Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic
expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 96:12737-12742
85. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, Tontonoz P 2003
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100:5419-5424
86. Commerford SR, Vargas L, Dorfman SE, Mitro N, Rocheford EC, Mak PA, Li X, Kennedy P, Mullarkey TL, Saez E 2007 Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol 21:3002-3012 87. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI 2003
Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J Biol Chem 278:48283-48291
88. Ferre T, Riu E, Bosch F, Valera A 1996 Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10:1213-1218
89. Baumann G, Amburn K, Shaw MA 1988 The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man.
Endocrinology 122:976-984
90. Baumann G, Frank SJ 2002 Metalloproteinases and the modulation of GH signaling. J Endocrinol 174:361-368
91. Baumbach WR, Horner DL, Logan JS 1989 The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 3:1199-1205
92. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821
93. Brooks AJ, Wooh JW, Tunny KA, Waters MJ 2008 Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol 40:1984-1989 94. Herrington J, Smit LS, Schwartz J, Carter-Su C 2000 The role of STAT
proteins in growth hormone signaling. Oncogene 19:2585-2597 95. Lanning NJ, Carter-Su C 2006 Recent advances in growth hormone
signaling. Rev Endocr Metab Disord 7:225-235
96. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J 1998 Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 273:31327-31336
97. Tollet P, Hamberg M, Gustafsson JA, Mode A 1995 Growth hormone signaling leading to CYP2C12 gene expression in rat hepatocytes involves phospholipase A2. J Biol Chem 270:12569-12577
98. Zhu T, Goh EL, Graichen R, Ling L, Lobie PE 2001 Signal transduction via the growth hormone receptor. Cell Signal 13:599-616
99. Rakesh K, Agrawal DK 2005 Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 70:649-657
100. Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E 2006 Negative regulation of growth hormone receptor signaling. Mol Endocrinol 20:241-253
101. Greenhalgh CJ, Alexander WS 2004 Suppressors of cytokine signalling and regulation of growth hormone action. Growth Horm IGF Res 14:200-206 102. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA,
Hilton DJ, Alexander WS 2000 Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069-1073
103. Chowen JA, Frago LM, Argente J 2004 The regulation of GH secretion by sex steroids. Eur J Endocrinol 151 Suppl 3:U95-100
104. De Vriese C, Delporte C 2008 Ghrelin: a new peptide regulating growth hormone release and food intake. Int J Biochem Cell Biol 40:1420-1424 105. Eden S 1979 Age- and sex-related differences in episodic growth hormone
secretion in the rat. Endocrinology 105:555-560
106. Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, Barkan AL 1998 Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Invest 102:153-164
107. Pincus SM, Gevers EF, Robinson IC, van den Berg G, Roelfsema F,
process irregularity than males in both humans and rats. Am J Physiol 270:E107-115
108. Chowen JA, Garcia-Segura LM, Gonzalez-Parra S, Argente J 1996 Sex steroid effects on the development and functioning of the growth hormone axis.
Cell Mol Neurobiol 16:297-310
109. Jansson JO, Ekberg S, Isaksson OG, Eden S 1984 Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat.
Endocrinology 114:1287-1294
110. Mode A, Wiersma-Larsson E, Strom A, Zaphiropoulos PG, Gustafsson JA 1989 A dual role of growth hormone as a feminizing and masculinizing factor in the control of sex-specific cytochrome P-450 isozymes in rat liver. J
Endocrinol 120:311-317
111. MacGeoch C, Morgan ET, Halpert J, Gustafsson JA 1984 Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15 beta-hydroxylase from liver microsomes of untreated female rats. J Biol Chem 259:15433-15439
112. Jaffe CA, Turgeon DK, Lown K, Demott-Friberg R, Watkins PB 2002 Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab 283:E1008-1015 113. Dhir RN, Dworakowski W, Thangavel C, Shapiro BH 2006 Sexually
dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 316:87-94
114. Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC 1998 Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine,
dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411-2416
115. Waxman DJ, O'Connor C 2006 Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 20:2613-2629
116. Tollet P, Lahuna O, Ahlgren R, Mode A, Gustafsson JA 1995 CCAAT/enhancer-binding protein-alpha-dependent transactivation of CYP2C12 in rat hepatocytes. Mol Endocrinol 9:1771-1781
117. Mauras N, Haymond MW 2005 Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15:19-27
118. Oscarsson J, Ottosson M, Johansson JO, Wiklund O, Marin P, Bjorntorp P, Bengtsson BA 1996 Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism 45:370-377
119. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Frick F, Enerback S, Lithell H, Eden S 1999 GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol 160:247-255 120. Friedman M, Byers SO, Elek SR 1970 Pituitary growth hormone essential for
regulation of serum cholesterol. Nature 225:464-467
121. Rudling M, Angelin B 1993 Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc Natl Acad Sci U S A 90:8851-8855
122. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A 89:6983-6987
123. Rudling M, Parini P, Angelin B 1997 Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J Clin Invest 99:2239-2245
124. Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, Norstedt G 2001 Gene expression profile of the aging process in rat liver:
normalizing effects of growth hormone replacement. Mol Endocrinol 15:308-125. Olsson B, Bohlooly YM, Brusehed O, Isaksson OG, Ahren B, Olofsson SO, 318
Oscarsson J, Tornell J 2003 Bovine growth hormone-transgenic mice have
major alterations in hepatic expression of metabolic genes. Am J Physiol Endocrinol Metab 285:E504-511
126. Runge D, Runge DM, Bowen WC, Locker J, Michalopoulos GK 1997 Matrix induced re-differentiation of cultured rat hepatocytes and changes of CCAAT/enhancer binding proteins. Biol Chem 378:873-881
127. Beigel J, Fella K, Kramer PJ, Kroeger M, Hewitt P 2008 Genomics and proteomics analysis of cultured primary rat hepatocytes. Toxicol In Vitro 22:171-181
128. Otsu K, Ito K, Kuzumaki T, Iuchi Y 2001 Differential regulation of liver-specific and ubiquitously-expressed genes in primary rat hepatocytes by the extracellular matrix. Cell Physiol Biochem 11:33-40
129. Oda H, Nozawa K, Hitomi Y, Kakinuma A 1995 Laminin-rich extracellular matrix maintains high level of hepatocyte nuclear factor 4 in rat hepatocyte culture. Biochem Biophys Res Commun 212:800-805
130. Gardmo C, Kotokorpi P, Helander H, Mode A 2005 Transfection of adult primary rat hepatocytes in culture. Biochem Pharmacol 69:1805-1813 131. Oda H, Nozawa K, Miyachi F, Shimizu A, Iwasaki Y, Kakinuma A 1997
High responsiveness to thyroid hormone of adult rat primary hepatocytes cultured on EHS-gel. Biosci Biotechnol Biochem 61:1590-1592
132. Bissell DM, Arenson DM, Maher JJ, Roll FJ 1987 Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 79:801-812 133. Nagaki M, Shidoji Y, Yamada Y, Sugiyama A, Tanaka M, Akaike T,
Ohnishi H, Moriwaki H, Muto Y 1995 Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 210:38-43
134. DiPersio CM, Jackson DA, Zaret KS 1991 The extracellular matrix
coordinately modulates liver transcription factors and hepatocyte morphology.
Mol Cell Biol 11:4405-4414
135. Kocarek TA, Schuetz EG, Guzelian PS 1993 Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel. Mol Pharmacol 43:328-334
136. Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B, Guzelian PS 1988 Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 134:309-137. Sidhu JS, Liu F, Omiecinski CJ 2004 Phenobarbital responsiveness as a 323
uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 292:252-264
138. Tollet P, Enberg B, Mode A 1990 Growth hormone (GH) regulation of cytochrome P-450IIC12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: a hormonal interplay with insulin, IGF-I, and thyroid hormone. Mol Endocrinol 4:1934-1942 139. Cherrington AD 1999 Banting Lecture 1997. Control of glucose uptake and
release by the liver in vivo. Diabetes 48:1198-1214
140. Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G 2001 Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson. J Biol Chem 276:31521-31527
141. Luo Y, Tall AR 2000 Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 105:513-520
142. Menke JG, Macnaul KL, Hayes NS, Baffic J, Chao YS, Elbrecht A, Kelly LJ, Lam MH, Schmidt A, Sahoo S, Wang J, Wright SD, Xin P, Zhou G, Moller DE, Sparrow CP 2002 A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a). Endocrinology 143:2548-2558
143. Mode A, Norstedt G, Simic B, Eneroth P, Gustafsson JA 1981 Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat.
Endocrinology 108:2103-2108
144. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, Quackenbush J, Lee NH, Norstedt G 2001 Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142:3163-3176
145. Elvidge G 2006 Microarray expression technology: from start to finish.
Pharmacogenomics 7:123-134
146. Dalma-Weiszhausz DD, Warrington J, Tanimoto EY, Miyada CG 2006 The affymetrix GeneChip platform: an overview. Methods Enzymol 410:3-28 147. Roberts PC 2008 Gene expression microarray data analysis demystified.
Biotechnol Annu Rev 14:29-61
148. Gardmo C, Swerdlow H, Mode A 2002 Growth hormone regulation of rat liver gene expression assessed by SSH and microarray. Mol Cell Endocrinol 190:125-133
149. Volle DH, Repa JJ, Mazur A, Cummins CL, Val P, Henry-Berger J, Caira F, Veyssiere G, Mangelsdorf DJ, Lobaccaro JM 2004 Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Mol Endocrinol 18:888-898
150. Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, Towler DA, Law RE, Hsueh WA, Bruemmer D 2005 Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res 96:e59-67
151. Hayashi R, Wada H, Ito K, Adcock IM 2004 Effects of glucocorticoids on gene transcription. Eur J Pharmacol 500:51-62
152. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV, Jr. 2008 Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49:2283-2301
153. Durrington PN, Newton RS, Weinstein DB, Steinberg D 1982 Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 70:63-73
154. Magnusson B, Asp L, Bostrom P, Ruiz M, Stillemark-Billton P, Linden D, Boren J, Olofsson SO 2006 Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arterioscler Thromb Vasc Biol 26:1566-1571
155. Motomura W, Inoue M, Ohtake T, Takahashi N, Nagamine M, Tanno S, Kohgo Y, Okumura T 2006 Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. Biochem Biophys Res Commun 340:1111-1118
156. Yen PM 2001 Physiological and molecular basis of thyroid hormone action.
Physiol Rev 81:1097-1142
157. Ahlgren R, Norstedt G, Baumbach WR, Mode A 1995 Hormonal regulation of the female enriched GH receptor/binding protein mRNA in rat liver. Mol Cell Endocrinol 113:11-17
158. Ameen C, Linden D, Larsson BM, Mode A, Holmang A, Oscarsson J 2004 Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am J Physiol Endocrinol Metab 287:E1039-1048
159. Lehrke M, Lebherz C, Millington SC, Guan HP, Millar J, Rader DJ, Wilson JM, Lazar MA 2005 Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha. Cell Metab 1:297-308
160. Gereben B, Salvatore D, Harney JW, Tu HM, Larsen PR 2001 The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1).
Mol Endocrinol 15:112-124
161. Sandelin A, Wasserman WW 2005 Prediction of nuclear hormone receptor response elements. Mol Endocrinol 19:595-606
162. Varga G, Su C 2007 Classification and predictive modeling of liver X receptor response elements. BioDrugs 21:117-124